Support for doctors
PrEP’D For Change recognises and is grateful for the ongoing work of healthcare professionals in Australia. By continuing to be a world leader in HIV prevention and treatment you’re helping to protect the physical and mental wellbeing of all Australians, and we'd like to say thank you.
When used as pre-exposure prophylaxis (PrEP) against human immunodeficiency virus (HIV) infection, the medicines in PrEP are listed on the PBS General Schedule with streamlined authority required.
Three bioequivalent versions are TGA approved and PBS listed, containing any one of these formulations:
Tenofovir Disoproxil Fumarate 300mg and Emtricitabine 200mg
Tenofovir Disoproxil Maleate 300mg and Emtricitabine 200mg
Tenofovir Disoproxil Phosphate 291mg and Emtricitabine 200mg
A maximum quantity of one pack containing 30 pills with no more than two repeats can be prescribed. Clinical guidelines require baseline tests before starting PrEP with return follow-up and repeat tests every three months.
PrEP resources for clinicians are available from the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM).
Update on PrEP for HIV Clinicians — This communique is for clinicians involved in HIV, who may be consulted about HIV PrEP.
The ASHM PrEP Guidelines Sept 2019 update — These clinical PrEP guidelines update the 2018 ASHM PrEP guidelines which were initially an adaptation and update of the 2014 United States Centers for Disease Control‘s PrEP guidelines. The Australian PrEP Guidelines have the benefits of having been written and edited by clinicians, epidemiologists and representatives of peak Australian HIV community organisations who have significant experience of PrEP in the clinical, research and real-world settings. These guidelines are written for clinicians who will be initiating PrEP and monitoring people taking PrEP and are designed to reflect Australia’s unique epidemiology. Please note these guidelines are a final version for interim use and are awaiting endorsement by the Blood Borne Viruses and Sexually Transmissible Infections Standing Committee.
Decision making in PrEP — This tool provides a prescribing pathway which summarises the key eligibility and recommended assessment for primary care providers in Australia who wish to prescribe PrEP and the ongoing patient education and monitoring requirements.
PrEP online learning module — This provides guidance for general practitioners to better understand and safely prescribe PrEP.
Telephone information and support — For Victoria, call 1800 889 887 or (03) 9076 2940. For New South Wales call 1800 451 624. For Western Australia, call 1800 671 130
ASHM Facebook Live Q+A Event: PrEPPING the Health Workforce — This event was recorded April 12, 2018 with:
Danielle Collins, HIV Nurse Practitioner at The Alfred
Dr Vincent Cornelisse, Sexual Health Physician at Prahran Market Clinic, Melbourne Sexual Health Centre and PhD Candidate at Monash University
Associate Professor Edwina Wright, Infectious Diseases Physician and clinical researcher at The Alfred, Monash University, The Burnet Institute and The Peter Doherty Institute for Infection and Immunity
Chris Williams, co-founder of PrEP'D For Change
Webinar: Prescribing Pre-Exposure Prophylaxis (PrEP) for HIV in General Practice — This webinar was recorded September 12, 2018